# Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

> **NCT00004206** · PHASE2 · UNKNOWN · sponsor: **University of Leicester**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** FOLFOX regimen
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00004206
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004206, "Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*